These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Novel glycobiomarker for ovarian cancer that detects clear cell carcinoma. Sogabe M; Nozaki H; Tanaka N; Kubota T; Kaji H; Kuno A; Togayachi A; Gotoh M; Nakanishi H; Nakanishi T; Mikami M; Suzuki N; Kiguchi K; Ikehara Y; Narimatsu H J Proteome Res; 2014 Mar; 13(3):1624-35. PubMed ID: 24498956 [TBL] [Abstract][Full Text] [Related]
3. [Ascites May Provide Useful Information for Diagnosis of Ovarian Cancer]. Stuchlíková E; Zahradníková M; Nenutil R; Valík D; Vojtěšek B; Novotný M; Hernychova L Klin Onkol; 2017; 30(Supplementum1):187-190. PubMed ID: 28471203 [TBL] [Abstract][Full Text] [Related]
4. The ascites N-glycome of epithelial ovarian cancer patients. Biskup K; Braicu EI; Sehouli J; Tauber R; Blanchard V J Proteomics; 2017 Mar; 157():33-39. PubMed ID: 28188862 [TBL] [Abstract][Full Text] [Related]
5. Proteomic identification of fucosylated haptoglobin alpha isoforms in ascitic fluids and its localization in ovarian carcinoma tissues from Mexican patients. Garibay-Cerdenares OL; Hernández-Ramírez VI; Osorio-Trujillo JC; Hernández-Ortíz M; Gallardo-Rincón D; Cantú de León D; Encarnación-Guevara S; Villegas-Pineda JC; Talamás-Rohana P J Ovarian Res; 2014 Feb; 7():27. PubMed ID: 24576319 [TBL] [Abstract][Full Text] [Related]
6. Vitronectin (Vn) glycosylation patterned by lectin affinity assays-A potent glycoproteomic tool to discriminate plasma Vn from cancer ascites Vn. Benachour H; Leroy-Dudal J; Agniel R; Wilson J; Briand M; Carreiras F; Gallet O J Mol Recognit; 2018 May; 31(5):e2690. PubMed ID: 29205553 [TBL] [Abstract][Full Text] [Related]
7. Changes in the expression of N- and O-glycopeptides in patients with colorectal cancer and hepatocellular carcinoma quantified by full-MS scan FT-ICR and multiple reaction monitoring. Darebna P; Novak P; Kucera R; Topolcan O; Sanda M; Goldman R; Pompach P J Proteomics; 2017 Feb; 153():44-52. PubMed ID: 27646713 [TBL] [Abstract][Full Text] [Related]
9. Mass spectrometric profiling reveals association of N-glycan patterns with epithelial ovarian cancer progression. Chen H; Deng Z; Huang C; Wu H; Zhao X; Li Y Tumour Biol; 2017 Jul; 39(7):1010428317716249. PubMed ID: 28681696 [TBL] [Abstract][Full Text] [Related]
10. O-Glycopeptide Truncation Strategy for Heterogeneous O-GalNAc Glycoproteomics Characterization. Liu L; Zhu H; Liu L; You X; Mao J; Wang Y; Liu X; Qin H; Dong M; Ye M Anal Chem; 2023 Jul; 95(26):10017-10024. PubMed ID: 37345258 [TBL] [Abstract][Full Text] [Related]
11. Designation of fingerprint glycopeptides for targeted glycoproteomic analysis of serum haptoglobin: insights into gastric cancer biomarker discovery. Lee J; Hua S; Lee SH; Oh MJ; Yun J; Kim JY; Kim JH; Kim JH; An HJ Anal Bioanal Chem; 2018 Feb; 410(6):1617-1629. PubMed ID: 29285644 [TBL] [Abstract][Full Text] [Related]
12. Glycomics and proteomics analyses of mouse uterine luminal fluid revealed a predominance of Lewis Y and X epitopes on specific protein carriers. Kuo CW; Chen CM; Lee YC; Chu ST; Khoo KH Mol Cell Proteomics; 2009 Feb; 8(2):325-42. PubMed ID: 18941134 [TBL] [Abstract][Full Text] [Related]
13. Identification of oncofetal fibronectin in patients with advanced epithelial ovarian cancer: detection in ascitic fluid and localization to primary sites and metastatic implants. Menzin AW; Loret de Mola JR; Bilker WB; Wheeler JE; Rubin SC; Feinberg RF Cancer; 1998 Jan; 82(1):152-8. PubMed ID: 9428492 [TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin-2 receptor alpha levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma. Sedlaczek P; Frydecka I; Gabryś M; Van Dalen A; Einarsson R; Harłozińska A Cancer; 2002 Nov; 95(9):1886-93. PubMed ID: 12404282 [TBL] [Abstract][Full Text] [Related]
15. Potential Significance of Peptidome in Human Ovarian Cancer for Patients With Ascites. Huang X; Zhou J; Tang R; Han S; Zhou X Int J Gynecol Cancer; 2018 Feb; 28(2):355-362. PubMed ID: 29240604 [TBL] [Abstract][Full Text] [Related]
16. Characteristic glycopeptides associated with extreme human longevity identified through plasma glycoproteomics. Miura Y; Hashii N; Ohta Y; Itakura Y; Tsumoto H; Suzuki J; Takakura D; Abe Y; Arai Y; Toyoda M; Kawasaki N; Hirose N; Endo T Biochim Biophys Acta Gen Subj; 2018 Jun; 1862(6):1462-1471. PubMed ID: 29580922 [TBL] [Abstract][Full Text] [Related]
17. N-glycoproteomic analyses of human intestinal enteroids, varying in histo-blood group geno- and phenotypes, reveal a wide repertoire of fucosylated glycoproteins. Nilsson J; Rimkute I; Sihlbom C; Tenge VR; Lin SC; Atmar RL; Estes MK; Larson G Glycobiology; 2024 Apr; 34(6):. PubMed ID: 38590172 [TBL] [Abstract][Full Text] [Related]
18. MS-based glycomic strategies for probing the structural details of polylactosaminoglycan chain on N-glycans and glycoproteomic identification of its protein carriers. Wang SH; Wu SW; Khoo KH Proteomics; 2011 Jul; 11(14):2812-29. PubMed ID: 21656680 [TBL] [Abstract][Full Text] [Related]
19. Glycoproteomic analyses of ovarian cancer cell lines and sera from ovarian cancer patients show distinct glycosylation changes in individual proteins. Li B; An HJ; Kirmiz C; Lebrilla CB; Lam KS; Miyamoto S J Proteome Res; 2008 Sep; 7(9):3776-88. PubMed ID: 18642944 [TBL] [Abstract][Full Text] [Related]
20. Stable isotope labeling of N-glycosylated peptides by enzymatic deglycosylation for mass spectrometry-based glycoproteomics. Kaji H; Isobe T Methods Mol Biol; 2013; 951():217-27. PubMed ID: 23296533 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]